SCHEMBL25841306

SCHEMBL25841306

N=C(NCP(O)O)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.49
CDK1 P06493 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
MTOR P42345 2/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
KIF11 P52732 2/20 0.42
TGM2 P21980 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
NAMPT P43490 1/20 0.42
BAZ1A Q9NRL2 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TRPV1 Q8NER1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25841012 0.80 EPHX2 (0.68) EPHX2MEN1KMT2AMTORHTT
SCHEMBL25841014 0.80 CDK1 (0.67) EPHX2CDK1MEN1KMT2ASMN1; SMN2
SCHEMBL25841134 0.79 EPHX2 (0.51) EPHX2CDK1MEN1KMT2AMTOR
SCHEMBL23328671 0.78 EPHX2 (0.54) EPHX2MEN1KMT2AMTORLMNA
SCHEMBL23328394 0.76 FPR2 (0.56) EPHX2CDK1MEN1KMT2ASMN1; SMN2
SCHEMBL23328894 0.76 CA12 (0.50) EPHX2CDK1MEN1KMT2AMTOR
SCHEMBL27214948 0.75 RAB9A (0.61) EPHX2MEN1KMT2ASMN1; SMN2MTOR
SCHEMBL23328672 0.75 EPHX2 (0.51) EPHX2MEN1KMT2AMTORLMNA
SCHEMBL11816841 0.72 RAB9A (0.57) EPHX2MEN1KMT2ASMN1; SMN2MTOR
SCHEMBL4099321 0.72 KIF11 (0.53) EPHX2CDK1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 EPHX2 2581/4885CDK1 1597/4885MEN1 1300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.